Yuko Nitahara
Osaka, 5458585, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Nationwide molecular epidemiology of Trypanosoma cruzi TcI in El Salvador using multi-locus sequence typing.
Journal: Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases
Published: May 18, 2026
Sustained antigen-specific CD8+ T cell immunity post-mRNA booster requires notch pathway activation.
Sustained antigen-specific CD8+ T cell immunity post-mRNA booster requires notch pathway activation.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: August 14, 2025
Adverse reactions following first three doses of the BNT162b2 mRNA COVID-19 vaccine: A prospective cohort study on relationships with individual characteristics and previous experience of adverse reactions.
Journal: Human vaccines & immunotherapeutics
Published: June 24, 2025
Natural Reservoir of Trypanosoma cruzi Found in Triatomines Targeting Humans: Results from Nation-wide Vector Surveillance in El Salvador.
Journal: JMA journal
Published: July 22, 2024
Association of gut commensal translocation with autoantibody production in systemic lupus erythematosus.
Journal: Rheumatology (Oxford, England)
Published: March 26, 2024
Factors impacting antibody kinetics, including fever and vaccination intervals, in SARS-CoV-2-naïve adults receiving the first four mRNA COVID-19 vaccine doses.
Journal: Scientific reports
Published: October 23, 2023
Differential cardiomyocyte transcriptomic remodeling during in vitro Trypanosoma cruzi infection using laboratory strains provides implications on pathogenic host responses.
Journal: Tropical medicine and health
Published: July 26, 2023
Immunogenicity and safety of COVID-19 vaccine in lung cancer patients receiving anticancer treatment: A prospective multicenter cohort study.
Journal: Human vaccines & immunotherapeutics
Published: November 12, 2022
Age-adjusted impact of prior COVID-19 on SARS-CoV-2 mRNA vaccine response.
Journal: Frontiers in immunology
Published: November 04, 2022
Last Updated: 09/26/2026